View Older Stories View More Recent Stories

Apr 26, 2017 04:00PM Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results
Apr 24, 2017 07:33AM Arrowhead Research (ARWR) Presents ARC-AAT Clinical Data at ILC
Apr 24, 2017 07:30AM Arrowhead Pharmaceuticals Presents ARC-AAT Clinical Data at The International Liver Congress™
Apr 20, 2017 11:30AM Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress™
Apr 5, 2017 07:32AM Arrowhead Research (ARWR) Announces Presentations at ILC
Apr 5, 2017 07:30AM Arrowhead Pharmaceuticals Announces Presentations at The International Liver Congress™
Mar 23, 2017 07:31AM Arrowhead Research (ARWR) Adopts Stockholder Rights Agreement
Mar 23, 2017 07:30AM Arrowhead Pharmaceuticals Adopts Stockholder Rights Agreement
Feb 6, 2017 04:00PM Arrowhead Reports Fiscal 2017 First Quarter Results
Jan 30, 2017 04:01PM Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results
Jan 9, 2017 06:26AM Arrowhead Research (ARWR) Says It's Had No Discussion on Potential Transaction with Silence
Jan 9, 2017 04:06AM Arrowhead Provides Response to New Minority Shareholder Announcement
Dec 14, 2016 04:00PM Arrowhead Reports Fiscal 2016 Year End Results
Dec 7, 2016 04:00PM Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results
Nov 29, 2016 04:04PM Arrowhead Research (ARWR) to Discontinue ARC-520, ARC-521, and ARC-AAT Development; Will Cut Workforce
Nov 29, 2016 04:03PM Arrowhead Pharmaceuticals Focuses Resources on Subcutaneous and Extra-Hepatic RNAi Therapeutics
Nov 21, 2016 11:34AM Arrowhead Research (ARWR) Reports Closing of License and Collaboration Agreement with Amgen (AMGN) on RNAi ARC-LPA Program
Nov 21, 2016 11:33AM Arrowhead Pharmaceuticals Announces Closing of License and Collaboration Agreement with Amgen
Nov 14, 2016 03:02PM Arrowhead Research (ARWR) Announces Presentations of ARC-LPA, ARC-F12 Data at AHA Scientific Sessions 2016
Nov 14, 2016 03:00PM Arrowhead Pharmaceuticals Presents New Data on ARC-F12 and ARC-LPA Using DPCsqTM Subcutaneous RNAi Delivery Vehicle
Nov 14, 2016 07:00AM Arrowhead Pharmaceuticals Presents New Data on ARC-AAT
Nov 9, 2016 06:41AM Arrowhead Research (ARWR) Announces FDA Clinical Hold Placed on Heparc-2004 Study
Nov 8, 2016 08:05PM Arrowhead Pharmaceuticals Provides Update on Heparc-2004 Study
Nov 1, 2016 07:30AM Arrowhead Pharmaceuticals to Present at Upcoming Conferences
Oct 20, 2016 10:00AM Arrowhead Pharmaceuticals to Present Data on ARC-AAT at The Liver Meeting®
Oct 6, 2016 09:22AM Pre-Open Stock Movers 10/06: (ALQA) (SCYX) (ZUMZ) Higher; (ALNY) (TWTR) (MDCO) Lower (more...)
Oct 6, 2016 07:32AM Arrowhead Research (ARWR),Spring Bank Pharma (SBPH) Enter Collaboration on Chronic HBV Treatments Development
Oct 6, 2016 07:30AM Arrowhead and Spring Bank Announce Clinical Collaboration for ARC-520 and SB 9200 in Chronic Hepatitis B
Sep 29, 2016 07:31AM Amgen (AMGN), Arrowhead Pharma (ARWR) Enter Two Cardiovascular-Focused License, Collaboration Agreements
Sep 29, 2016 07:31AM Amgen (AMGN), Arrowhead Pharmaceuticals (ARWR) Enter Collaborations on Two Cardiovascular Therapies
Sep 29, 2016 07:30AM Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Sep 7, 2016 07:30AM Arrowhead Pharmaceuticals Doses First Patient with Hepatitis B in Multiple Ascending Dose Portion of Phase 1/2 Study of ARC-521
Sep 6, 2016 07:31AM Arrowhead Research (ARWR) Initiated Phase 2 Clinical Study of ARC-AAT in AATD
Sep 6, 2016 07:30AM Arrowhead Pharmaceuticals Initiates Phase 2 Study of ARC-AAT
Sep 1, 2016 07:30AM Arrowhead Pharmaceuticals to Present at Upcoming September Conferences
Aug 12, 2016 07:30AM Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Aug 9, 2016 04:01PM Arrowhead Reports Fiscal 2016 Third Quarter Results
Aug 9, 2016 09:06AM Arrowhead Research (ARWR) Prices $45M Private Stock Offering at $5.90/Share
Aug 9, 2016 09:01AM Arrowhead Pharmaceuticals Prices $45 Million Private Offering
Aug 1, 2016 04:01PM Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Third Quarter Results
Jul 6, 2016 07:30AM Arrowhead Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
Jun 9, 2016 07:39AM Arrowhead Research (ARWR) Begins Phase 1/2 Single and Multiple Dose Study of HBV Candidate ARC-521
Jun 9, 2016 07:30AM Arrowhead Pharmaceuticals Initiates Phase 1/2 Single and Multiple Dose Study of Hepatitis B Candidate ARC-521
Jun 3, 2016 07:30AM Arrowhead Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference
May 10, 2016 04:01PM Arrowhead Reports Fiscal 2016 Second Quarter Results
May 6, 2016 12:00PM Arrowhead Pharmaceuticals’ Preclinical Candidate ARC-LPA Achieves 98% Knockdown and Long Duration of Effect after Subcutaneous Administration
May 3, 2016 04:01PM Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Second Quarter Results
Apr 29, 2016 07:30AM Arrowhead Pharmaceuticals to Present at Upcoming May Conferences
Apr 28, 2016 09:20AM Arrowhead Research (ARWR) Files for Clearance to Begin Phase 1/2 Study of ARC-521
Apr 28, 2016 07:30AM Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521
View More Recent Stories View Older Stories